Observational studyIntegrative cancer therapies

Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer.

Youngbae Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.